Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sirolimus in patients with metastatic mismatch repair-deficient solid tumors after prior immunotherapy has been terminated; results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mismatch Repair Deficient Solid Tumors

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Metastatic dMMR Solid Cancer, Solid Tumor | Phase 2 | Status: TERMINATED | Results posted: 2024-07-25